We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
EU says it is ‘ready to discuss’ move to rip up intellectual property rights but drugmakers object
Shares in Covid 19 vaccine makers hit on worries waiver would harm profit and innovation
French fishing boats converge on island to protest against post-Brexit restrictions on their activity
Israel’s Future Meat pulls forward timetable for reaching price parity with real poultry
One of world’s largest developers has done $11bn of deals in belief companies need physical space
Trump’s influence is destroying a political tradition that used to value truth-telling
Fake news, like conjuring, plays on our weaknesses — but with a little attention, we can fight back
More and more daytraders and institutional investors shift their attention to more speculative assets
World’s biggest brewer names head of its North America business Michel Doukeris as successor
Multinationals under pressure to take a stand on Xinjiang ahead of winter games
Frontrunner Pedro Castillo’s embrace of Marxism has some ‘looking to get money out’ before June election
Japanese group follows rival Sony in saying supply crunch threatens sales of gaming hardware
Strong numbers could pile pressure on Fed to rethink its ultra-supportive monetary policies
It may not stop manufacturing bottlenecks but symbolism of Washington’s IP waiver is immense
Contracting the virus was just the start of one FT journalist’s ordeal
Out go gyms and free meals, in come gong baths and financial advice
Mark Gordon’s comments reflect brewing backlash in fossil fuel-reliant US states against climate policy
SEC chair highlights concentration risk among big trading firms in House testimony
Auction of first private ticket could boost company’s flagging efforts in the billionaire space race
Driver shortage slows recovery but CEO says ‘starting to fire on all cylinders’ amid reopenings
US president’s rescue plans upend the framework we use to understand the role of policy
Fiat owner Stellantis no longer needs to buy credits from Elon Musk’s group to meet CO2 goals
Move follows ruling by constitutional court criticising previous climate goals
The eating habits of western countries are unsustainable
The temporary suspension of vaccine patents could enrage pharma industry
As the novel post-viral syndrome claims millions of sufferers, we look at the best treatments to boost your overall health
Businesses and residents want a coherent vision for the UK capital’s recovery, but no return to ‘business as usual’
An embrace of tech has helped some firms boost productivity and better serve clients
Jabre Capital is targeting investments in areas such as renewable energy and online education
Shares in CanSino and Fosun Pharma tumble on prospect of jump in global vaccine supply
BaFin rebuffs call from crypto exchange to remove warning on securities rules
International Edition
